Genedata Joins Danaher Corporation

Genedata and Danaher share a vision of accelerating discovery and development of critical therapeutics

20-Aug-2024
Computer-generated image

Symbolic image

Genedata AG, provider of software solutions for biopharmaceutical R&D, has been acquired by Danaher Corporation.

Founded in 1997 and headquartered in Basel, Switzerland, Genedata is at the forefront of transforming data into intelligence for the life sciences industry. Genedata delivers scalable and open solutions that enhance R&D productivity, serving top global biopharmaceutical companies and innovative biotechnology organizations around the globe. 

Genedata’s offerings are expected to add to Danaher’s broad workflow solutions that help accelerate the speed of drug discovery, development, and manufacturing for critical new therapies. Over the past several years, Genedata and Danaher have engaged in several successful collaborations.

“Genedata is a global market leader in digitalizing R&D processes to help accelerate the delivery of lifesaving and personalized medicines. Our achievements are driven by the dedication and expertise of our teams, whose efforts have been instrumental in earning the trust of our customers,” said Othmar Pfannes, Ph.D., Founder and CEO of Genedata. “As a Danaher operating company, Genedata will seek to continue to attract the brightest talent and solve our customers’ hardest problems globally.” 

Other news from the department business & finance

More news from our other portals

Recognise, understand, heal: The World of Diagnostics